Growth hormone, lymphocytes and macrophages

Biochemical Pharmacology

Volumn 38, Issue 5, 1989, Pages 705-713

  Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

GROWTH HORMONE DEFICIENCY; HEMATOPOIESIS; IMMUNOREGULATION; LYMPHOCYTE; MACROPHAGE; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; THYMUS;

ANIMAL; GROWTH HORMONE; HEMATOPOIESIS; HUMAN; LYMPHOCYTES; MACROPHAGES; PHAGOCYTES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; THYMUS GLAND;

EID: 0024512036     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(89)90222-0     Document Type: Article

References (103)

1. Relationship between thymus and hypophysis
2. Hormones and immunologic capacity I. Effect of heterologous anti-growth hormone (ASTH) antiserum on thymus and peripheral lymphatic tissue in mice. Induction of a wasting syndrome
3. Thymus, peripheral lymphoid tissues, and immunological responsiveness of the pituitary dwarf mouse
4. The growth of different organs of normal and dwarfed Snell mice, before and during growth hormone therapy
5. Hormones and the immunological capacity III. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse
6. Immunodeficiency of the thymus-dependent system of the Ames dwarf mouse
7. Improvement in clinical condition and thymus morphologic features associated with growth hormone treatment of immunodeficient dwarf dogs
8. Hormones and immunological capacity II. Reconstitution of antibody production in hormonally deficient mice by somatotropic hormone, thyrotropic hormone and thyroxin
9. Effects of hormones on development and function of lymphoid tissues: Synergistic action of thyroxin and somatotropic hormone in pituitary dwarf mice
10. Hormones and the immunological capacity IV. Restorative effects of developmental hormones or of lymphocytes on the immunodeficiency syndrome of the dwarf mouse
11. Immunological studies of the Snell-Bagg pituitary dwarf mouse
12. Immunological competence in Snell-Bagg pituitary dwarf mice: Response to the contact-sensitizing agent oxazolone
13. T and B lymphocytes in pituitary dwarf Snell-Bagg mice
14. Familial syndrome with panhypopituitarism, hypo-plasia of the hypophysis, and poorly developed sella turcica
15. X-linked hypogammaglobulinemia and isolated growth hormone deficiency
16. Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone
17. Antibody-mediated immunodeficiency in short-limbed dwarfism
18. Immunological studies in patients with isolated growth hormone deficiency
19. Thymic hormone activity and spontaneous auto-immunity in dwarf mice and their littermates
20. Humoral and cell-mediated immunity in growth hormone-deficient children: Effect of therapy with human growth hormone
21. Effects of human growth hormone on immune functions: In vitro studies on cells of normal and growth hormone-deficient children
22. Endo-crinological studies in ataxiatelangiectasia and other immunological deficiency diseases
23. A case of apparent hypopituitarism complicating chronic inflammatory bowel disease in childhood and adolescence
24. Severe growth retardation in children with inflammatory bowel disease
25. Weight increase of body and lymphatic tissues in dwarf mice treated with human chorionic somatomammotropin (HCS)
26. Effect of pituitary growth hormone on lymphatic tissues, thoracic duct lymph flow, lymph protein and lymphocyte out- put in the rat
27. Adrenotropic activity of mammo-somatotropic tumors in rats and mice: Biologic aspects
28. Effect of growth hormone on the metabolism of thymus and on the immune response against sheep erythrocytes
29. Participation of hormone in the early stages of the immune response
30. Effects of growth hormone on the adult canine thymus
31. 3 pituitary adenoma cells can reverse thymic aging in rats
32. Growth hormone treatment stimulates thymulin production in aged dogs
33. Specific binding of growth hormone to thymocytes
34. Human growth hormone radioreceptor assay using cultured human lymphocytes
35. 125I-human growth hormone to specific receptors in human cultured lymphocytes
36. Human growth hormone receptors in human circulating lymphocytes
37. Growth hormone receptors in lymphocytes of growth hormone-deficient children
38. Specific growth hormone receptors on human peripheral mononuclear cells: Reexpression, identification, and characterization
39. Interaction between thymic hormone and hypophyseal growth hormone on production of precipitating antibodies in the rat
40. Enhanced growth and immune development in dwarf chickens treated with mammalian growth hormone and thyroxin
41. Regulation of immunity in rats by lactogenic and growth hormones
42. Immunomodulation in rats by transplantable anterior pituitary tumors
43. Influence of the thymus-corticotropin-growth hormone interaction on the rejection of skin allografts in the rat
44. Role of growth hormone in regulating T-dependent immune events in aged, nude, and transgenic rodents
45. Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro
46. Human leukemic cells: Effects of human growth hormone
47. Possible effects of growth hormone on development of acute lymphoblastic leukemia
48. Modulation of lymphoproliferation by human growth hormone
49. Effects of growth hormone on lymphocyte transformation in cell culture
50. The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes
51. Regulation of natural killer activity in vivo III. Effect of hypo-physectomy and growth hormone treatment on the natural killer activity of the mouse spleen cell population
52. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion
53. Production of immunoreactive growth hormone by mononuclear leukocytes
54. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine
55. A newly defined property of somatotropin: Priming of macrophages for production of Superoxide anion
56. Effect of growth hormone on the metabolic activity of phagocytes of peripheral blood in pituitary dwarfs and acromegaly
57. Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs
58. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor 1/somatomedin C and human growth hormone
59. Growth hormone: Species specific stimulation of erythropoiesis in vitro
60. Growth hormone modulation of murine erythroleukemia cell growth in vitro
61. Growth hormone response to thyrotropin-releasing hormone in cancer patients
62. Impaired responses of growth hormone and blood eosinophils to l-dopa in atopy
63. The chemistry of growth hormone and the lactogenic hormones
64. Structure of cloned DNA complementary to rat prolactin messenger RNA
65. Growth hormone receptor and serum binding protein Purification cloning and expression
66. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family
67. Prolactin and growth hormone: Specialists on one hand and mutual mimics on the other
68. Age-related change in the twentyfour spontaneous secretion of growth hormone
69. Effect of aging on human plasma growth hormone response to clonidine
70. mpaired ability of old male rats to secrete growth hormone in vivo but not in vitro in response to hpGRF (1–44)
71. Growth hormone releasing hormone induced release of growth hormone in aging male rats: Dependence on pharmacological manipulation and endogenous somatostatin release
72. Decreased pulsatile release of growth hormone in old male rats
73. Hyposomatomedinemia in the men of a veterans administration nursing home: Prevalence and correlates
74. Prolactin and other lactogenic hormones
75. A pituitary-thymus connection during aging
76. Neuroendocrine-thymus interactions: Perspectives for intervention in aging
77. Growth hormone induced T cell differentiation
78. Prolactin receptors on human lymphocytes and their modulation by cyclosporine
79. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine
80. Prolactin binding sites in human erythrocytes and lymphocytes
81. Hormonal regulation of the immune response II. Influence of pituitary and adrenal activity on immune responsiveness in vitro
82. The influence of adrenocorticotropic and growth hormones on anti-body formation
83. Endocrine effects on leukocytopoiesis in the rat I. Evidence for growth hormone secretion as the leukocytopoetic stimulus following acute cortisol-induced lymphopenia
84. Somatomedin production and response to mitogen by lymphocytes in children with growth hormone deficiency
85. Suppression of immune function in growth hormone-deficient children during treatment with human growth hormone
86. Growth hormone and lymphocyte transformation
87. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice
88. Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping
89. Hemopoiesis in pituitary dwarfs treated with human growth hormone and testosterone
90. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immuno-reactivity
91. The circulating growth hormone (GH)-binding protein complex: A major constituent of plasma GH in man
92. 3 cells
93. Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitro
94. Growth hormone releasing action of a Pseudomonas endotoxin (Piromen)
95. Suppression of prolactin in pigs by Escherichia coli endotoxin
96. Central action of interleukin-1 in altering the release of TSH, growth hormone, and prolactin in the male rat
97. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells
98. The role of tumor necrosis factor (cachectin) in cachexia
99. Growth hormone and prostatic tumours: Localization using a monoclonal human growth hormone antibody
100. Growth hormone and malignancy
101. Growth hormone use